
    
      The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetic
      profile of ascending multiple oral doses of AMG 581 in healthy subjects or subjects with
      schizophrenia or schizoaffective disorder on antipsychotic medication. The study will also
      assess the effects of AMG 581 on midazolam PK in healthy subjects or subjects with
      schizophrenia or schizoaffective disorder on antipsychotic medication.
    
  